LINQ II Insertable Cardiac Monitor vs Zio XT ECG Monitoring System

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
LINQ II Insertable Cardiac Monitor
by Medtronic
VS
Zio XT ECG Monitoring System
by iRhythm Technologies

AI Verdict

Tool A, the Medtronic LINQ II, is an insertable cardiac monitor providing long-term, continuous heart rhythm monitoring for up to 4.5 years, suitable for diagnosing elusive arrhythmias. In contrast, Tool B, the iRhythm Zio XT, offers a wearable ECG biosensor for shorter-term, ambulatory monitoring up to 14 days, typically used for initial diagnostic workups. While both utilize AI for arrhythmia detection, their distinct deployment methods and monitoring durations cater to different clinical needs and patient profiles.

Choose LINQ II Insertable Cardiac Monitor if…

Choose the LINQ II Insertable Cardiac Monitor if you require long-term, continuous heart rhythm monitoring for up to 4.5 years, particularly for patients with infrequent or cryptic arrhythmias where a definitive diagnosis requires extended observation. This tool is ideal when patient compliance with external devices is a concern, or when remote programming and MRI compatibility are crucial for ongoing patient management.

View LINQ II Insertable Cardiac Monitor →

Choose Zio XT ECG Monitoring System if…

Choose the Zio XT ECG Monitoring System if you need a non-invasive, wearable solution for continuous cardiac monitoring for up to 14 days. This system is best suited for initial evaluations of suspected arrhythmias where patient comfort and convenience are paramount, or when a shorter, yet comprehensive, diagnostic window is sufficient without the need for an implantable device.

View Zio XT ECG Monitoring System →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature LINQ II Insertable Cardiac Monitor Zio XT ECG Monitoring System
Pricing Unknown Contact for pricing
Deployment Subcutaneous implant with remote monitoring via mobile app or home communicator. Cloud-based (AWS EC2 platform), no on-premise hardware required.
BAA Available Unknown Yes AI-estimated
FDA Status Cleared AI-estimated Yes AI-estimated
HIPAA Unknown Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Zio XT ECG Monitoring System

The Zio XT offers superior initial usability due to its non-invasive, wearable patch design that requires no surgical procedure. Its wire-free, water-resistant nature and high reported patient compliance for up to 14 days enhance comfort and ease of daily living during the monitoring period.

Clinical Value

LINQ II Insertable Cardiac Monitor

The LINQ II provides significantly longer continuous monitoring, up to 4.5 years, which is critical for detecting infrequent or paroxysmal arrhythmias that shorter-term monitors might miss. Its MRI compatibility and pediatric indication further broaden its clinical utility for a wider patient population.

Pricing & Value

Zio XT ECG Monitoring System

Zio XT offers greater pricing transparency with publicly available per-patient costs in the UK and proposed US Medicare rates. This allows healthcare systems to more easily evaluate the financial implications and value proposition compared to LINQ II's undisclosed enterprise-negotiated pricing.

Enterprise Readiness

LINQ II Insertable Cardiac Monitor

Medtronic, as a long-established global medical device company, demonstrates robust enterprise readiness with over 1 million patients having received their ICMs worldwide. Its hybrid deployment model and extensive track record provide a proven, scalable solution for health systems of all sizes.

Innovation

LINQ II Insertable Cardiac Monitor

LINQ II showcases innovation through its extended monitoring duration of up to 4.5 years, remote programming capabilities, and advanced AccuRhythm AI algorithms, including an innovative PVC detection algorithm. These features push the boundaries of long-term, intelligent cardiac monitoring.

Support & Docs

Tie

Both Medtronic and iRhythm provide comprehensive support and documentation, including patient manuals, clinician guides, and accessible phone support. Without specific comparative metrics on the quality or breadth of these services, it is difficult to definitively distinguish one as superior.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature LINQ II Insertable Cardiac Monitor Zio XT ECG Monitoring System
Product Name LINQ II Insertable Cardiac Monitor Zio XT ECG Monitoring System
Company Medtronic iRhythm Technologies
Monitoring Duration Up to 4.5 years of continuous monitoring Up to 14 days of continuous cardiac monitoring
Key Technology AccuRhythmu2122 AI algorithms, Insertable Cardiac Monitor Wearable single-lead ECG biosensor, FDA-cleared deep-learned AI algorithm
Patient Interface MyCareLink Heartu2122 mobile app for data transmission, MyCareLink Relayu2122 home communicator option Wearable single-lead ECG biosensor, Patient-activated button for symptomatic event logging
Specialties Cardiology Cardiology, Emergency Medicine, Internal Medicine

Videos

Demos, reviews, and walkthroughs featuring LINQ II Insertable Cardiac Monitor and Zio XT ECG Monitoring System.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The Medtronic LINQ II is an insertable cardiac monitor (ICM) designed for long-term, continuous heart rhythm monitoring for up to 4.5 years. In contrast, the iRhythm Zio XT is a wearable, single-lead ECG biosensor that provides continuous cardiac monitoring for up to 14 days.
The LINQ II utilizes AccuRhythmu2122 AI algorithms for enhanced accuracy in diagnosing arrhythmias, including an innovative PVC detection algorithm. The Zio XT employs a proprietary, FDA-cleared deep-learned AI algorithm for ECG data analysis, which is overseen by expert review for accurate arrhythmia detection and diagnosis.
The LINQ II is a small, insertable device that communicates via the MyCareLink Heartu2122 mobile app or MyCareLink Relayu2122 home communicator, offering discreet, long-term monitoring. The Zio XT is a water-resistant, wearable patch with no external leads or wires, allowing normal daily activities including showering, and features a patient-activated button for symptomatic event logging, contributing to high patient compliance.
The Medtronic LINQ II is MRI compatible at both 1.5 and 3.0T. The provided information for the Zio XT ECG Monitoring System does not specify MRI compatibility, and some sources indicate it should not be used near strong magnetic fields or devices such as MRI.
The LINQ II has a pediatric indication for patients aged 2 years and older and is suited for patients requiring long-term monitoring for infrequent symptoms. The Zio XT is an external, non-invasive monitor for up to 14 days, typically used for patients with transient symptoms or those requiring ambulatory cardiac monitoring.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform
AISAP Cardio vs Rapid Enterprise Platform
AngioWaveNet vs Rapid Enterprise Platform
CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring LINQ II Insertable Cardiac Monitor or Zio XT ECG Monitoring System

Backers

Who funded each tool's parent company.

Zio XT ECG Monitoring System

AI Tool Finder
AI-powered search. Results may not be comprehensive.